Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

The role of neopterin in atherogenesis and cardiovascular risk assessment.

Fuchs D, Avanzas P, Arroyo-Espliguero R, Jenny M, Consuegra-Sanchez L, Kaski JC.

Curr Med Chem. 2009;16(35):4644-53. Review.

PMID:
19903144
2.

Role of neopterin in cardiovascular medicine.

Avanzas P, Arroyo-Espliguero R, Kaski JC.

Rev Esp Cardiol. 2009 Nov;62(11):1341-2; author reply 1342-3. No abstract available.

3.

Neopterin and coronary artery disease.

Avanzas P, Domínguez-Rodríguez A, Arroyo-Espliguero R, Kaski JC.

J Cardiol. 2009 Oct;54(2):344-5; author reply 345-6. doi: 10.1016/j.jjcc.2009.07.005. Epub 2009 Sep 8. No abstract available.

4.

Neopterin and cardiovascular disease: growing evidence for a role in patient risk stratification.

Avanzas P, Arroyo-Espliguero R, Kaski JC.

Clin Chem. 2009 Jun;55(6):1056-7. doi: 10.1373/clinchem.2009.127084. Epub 2009 Apr 24. No abstract available.

5.

C-reactive protein predicts functional status and correlates with left ventricular ejection fraction in patients with chronic stable angina.

Arroyo-Espliguero R, Avanzas P, Quiles J, Kaski JC.

Atherosclerosis. 2009 Jul;205(1):319-24. doi: 10.1016/j.atherosclerosis.2008.12.018. Epub 2008 Dec 14.

PMID:
19251259
6.

Neopterin - marker of coronary artery disease activity or extension in patients with chronic stable angina?

Avanzas P, Arroyo-Espliguero R, Kaski JC.

Int J Cardiol. 2010 Sep 24;144(1):74-5; author reply 75-6. doi: 10.1016/j.ijcard.2008.12.029. Epub 2009 Jan 20. No abstract available.

PMID:
19157605
7.

Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease.

Arroyo-Espliguero R, Avanzas P, Quiles J, Kaski JC.

Atherosclerosis. 2009 May;204(1):239-43. doi: 10.1016/j.atherosclerosis.2008.08.009. Epub 2008 Aug 15.

PMID:
18823889
8.

Pacemaker lead displacement: mechanisms and management.

Fuertes B, Toquero J, Arroyo-Espliguero R, Lozano IF.

Indian Pacing Electrophysiol J. 2003 Oct 1;3(4):231-8. No abstract available.

9.

Microvascular dysfunction in cardiac syndrome X: the role of inflammation.

Arroyo-Espliguero R, Kaski JC.

CMAJ. 2006 Jun 20;174(13):1833. No abstract available.

10.

Inflammatory biomarkers of coronary atheromatous plaque vulnerability.

Avanzas P, Arroyo-Espliguero R, Garcia-Moll X, Kaski JC.

Panminerva Med. 2005 Jun;47(2):81-91. Review.

PMID:
16210993
11.

Neopterin: still a forgotten biomarker.

Kaski JC, Avanzas P, Arroyo-Espliguero R.

Clin Chem. 2005 Oct;51(10):1902-3; author reply 1903. No abstract available.

12.

[Chronic obstructive pulmonary disease and cardiovascular risk].

Izquierdo Alonso JL, Arroyo-Espliguero R.

Arch Bronconeumol. 2005 Aug;41(8):410-2. Spanish. No abstract available.

13.
14.

Multiple complex stenoses and chronic stable angina pectoris.

Avanzas P, Arroyo-Espliguero R, Carlos Kaski J.

Int J Cardiol. 2005 Jul 20;102(3):549-50. Epub 2004 Dec 15. No abstract available.

PMID:
16004910
15.

Neutrophil count and complex lesions in patients with coronary artery disease.

Kaski JC, Avanzas P, Arroyo-Espliguero R.

Arterioscler Thromb Vasc Biol. 2005 Jun;25(6):e112; author reply e112. No abstract available.

PMID:
15923537
16.

Silent myocardial ischaemia: clinical relevance and treatment.

Kaski JC, Cosín Sales J, Arroyo Espliguero R.

Expert Opin Investig Drugs. 2005 Apr;14(4):423-34. Review.

PMID:
15882118
17.

Angiotension-converting enzyme gene I/D polymorphism in patients with angina and normal coronary arteriograms.

Vázquez-Rey E, Montgomery HE, Arroyo-Espliguero R, Brown S, Kaski JC.

Int J Cardiol. 2005 Feb 15;98(2):339-40.

PMID:
15686789
18.

CD14 C(-260)T promoter polymorphism and prevalence of acute coronary syndromes.

Arroyo-Espliguero R, El-Sharnouby K, Vázquez-Rey E, Kalidas K, Jeffery S, Kaski JC.

Int J Cardiol. 2005 Feb 15;98(2):307-12.

PMID:
15686783
19.

Elevated serum neopterin predicts future adverse cardiac events in patients with chronic stable angina pectoris.

Avanzas P, Arroyo-Espliguero R, Quiles J, Roy D, Kaski JC.

Eur Heart J. 2005 Mar;26(5):457-63. Epub 2005 Jan 31.

PMID:
15684278
20.

Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T.

Roy D, Quiles J, Aldama G, Sinha M, Avanzas P, Arroyo-Espliguero R, Gaze D, Collinson P, Carlos Kaski J.

Int J Cardiol. 2004 Nov;97(2):297-301.

PMID:
15458698
21.

Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris.

Zouridakis E, Avanzas P, Arroyo-Espliguero R, Fredericks S, Kaski JC.

Circulation. 2004 Sep 28;110(13):1747-53. Epub 2004 Sep 20.

PMID:
15381646
22.

CD14 and toll-like receptor 4: a link between infection and acute coronary events?

Arroyo-Espliguero R, Avanzas P, Jeffery S, Kaski JC.

Heart. 2004 Sep;90(9):983-8. Review.

23.

Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes.

Avanzas P, Arroyo-Espliguero R, Cosín-Sales J, Aldama G, Pizzi C, Quiles J, Kaski JC.

Heart. 2004 Aug;90(8):847-52.

24.

Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina.

Avanzas P, Arroyo-Espliguero R, Cosín-Sales J, Quiles J, Zouridakis E, Kaski JC.

Atherosclerosis. 2004 Jul;175(1):151-7.

PMID:
15186960
25.

[Atherosclerotic coronary artery disease: usefulness of C-reactive protein for the identification of the vulnerable plaque and the vulnerable patient].

Arroyo-Espliguero R, Avanzas P, Kaski JC.

Rev Esp Cardiol. 2004 May;57(5):375-8. Spanish. No abstract available.

26.

C-reactive protein elevation and disease activity in patients with coronary artery disease.

Arroyo-Espliguero R, Avanzas P, Cosín-Sales J, Aldama G, Pizzi C, Kaski JC.

Eur Heart J. 2004 Mar;25(5):401-8.

PMID:
15033252
27.

Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease.

Avanzas P, Arroyo-Espliguero R, Cosin-Sales J, Quiles J, Zouridakis E, Kaski JC.

Am J Cardiol. 2004 Mar 1;93(5):627-9.

PMID:
14996595
28.

Chronic inflammation and increased arterial stiffness in patients with cardiac syndrome X.

Arroyo-Espliguero R, Mollichelli N, Avanzas P, Zouridakis E, Newey VR, Nassiri DK, Kaski JC.

Eur Heart J. 2003 Nov;24(22):2006-11.

PMID:
14613736
29.

Neopterin--a forgotten biomarker.

Kaski JC, Avanzas P, Arroyo-Espliguero R.

J Am Coll Cardiol. 2003 Sep 17;42(6):1142-3. No abstract available.

30.

Late displacement of a ventricular pacing lead after respiratory therapy.

Arroyo Espliguero R, Oteo Domínguez JF, Castedo Mejuto E, Antorrena Miranda I, Ortigosa Aso J, Cañas Cañas A, Artaza Andrade M.

Pacing Clin Electrophysiol. 2001 Nov;24(11):1693-5.

PMID:
11816642

Supplemental Content

Loading ...
Support Center